The effect of CYP2C19 gene polymorphism on clinical outcomes in patients with CAD receiving antiplatelet therapy

被引：0
|
作者：
Liu, W. [1 ]
Xi, Z. W. [1 ]
Zhou, Y. J. [1 ]
机构：
[1] Beijing Anzhen Hosp, Caridiol, Beijing, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4010
引用
收藏
页码：837 / 837
页数：1
相关论文
共 50 条
  • [21] Clinical outcomes of CYP2C19 genotype-guided antiplatelet therapy: existing evidence and future directions
    Klein, Melissa D.
    Lee, Craig R.
    Stouffer, George A.
    PHARMACOGENOMICS, 2018, 19 (13) : 1039 - 1046
  • [22] Correlation between clopidogrel low response and CYP2C19 gene polymorphism in CAD patients after PCI
    Yang, Shengli
    Sun, Yaqin
    Yang, Yong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C136 - C136
  • [23] CYP2C19 Genetic Polymorphism, Rabeprazole and Esomeprazole Have no Effect on the Antiplatelet Action of Clopidogrel
    El-Halabi, Mustapha M.
    Zgheib, Nathalie
    Mansour, Nabil M.
    Malli, Ahmad
    Ghaith, Ola A.
    Mahfouz, Rami
    Alam, Samir
    Sharara, Ala I.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 62 (01) : 41 - 49
  • [24] Different Influences of CYP2C19 Gene Polymorphisms on Antiplatelet Effect of Clopidogrel and Ticlopidine
    Asai, Toru
    Ishiguro, Hisaaki
    Umemoto, Norio
    Morishima, Mikio
    Harata, Syuji
    Shimizu, Kiyokazu
    Murohara, Toyoaki
    Maeda, Akimitsu
    Ando, Hitoshi
    Fujimura, Akio
    CIRCULATION, 2010, 122 (21)
  • [25] Improvement of Clopidogrel Hypo-Responsiveness by Cilostazol Addition to the Dual Antiplatelet Therapy in PCI Patients Carrying CYP2C19 Gene Polymorphism
    Tanigawa, Takashi
    Nakata, Tomoyuki
    Ito, Masaaki
    Nishikawa, Masakatsu
    CIRCULATION, 2010, 122 (21)
  • [26] Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients
    Ahmed, Sagheer
    Gul, Saima
    Siraj, Sami
    Hussain, Abrar
    Sheikh, Fahad Sultan
    Shah, Saeed Ullah
    Janjua, Kholood
    Khan, Hizbullah
    Hamdard, Mohammad Hamid
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [27] Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy
    Yamamoto, Koichiro
    Hokimoto, Seiji
    Chitose, Tadasuke
    Morita, Kazunori
    Ono, Takamichi
    Kaikita, Koichi
    Tsujita, Kenichi
    Abe, Tomohide
    Deguchi, Mariko
    Miyagawa, Haruna
    Saruwatari, Junji
    Sumida, Hitoshi
    Sugiyama, Seigo
    Nakagawa, Kazuko
    Ogawa, Hisao
    JOURNAL OF CARDIOLOGY, 2011, 57 (02) : 194 - 201
  • [28] Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients
    Sagheer Ahmed
    Saima Gul
    Sami Siraj
    Abrar Hussain
    Fahad Sultan Sheikh
    Saeed Ullah Shah
    Kholood Janjua
    Hizbullah Khan
    Mohammad Hamid Hamdard
    Scientific Reports, 12
  • [29] The effect of CYP2C19*2 polymorphism on clopidogrel resistance in COPD patients
    Kilik, Zeliha Funda
    Akalin, Hilal
    Bayramov, Ruslan
    Erdem, Yakut
    Dundar, Munis
    JOURNAL OF BIOTECHNOLOGY, 2017, 256 : S80 - S80
  • [30] CYP2C19*3 polymorphism in patients with endometriosis
    Bento, I. A.
    Silva, K. S. F. e
    Moura, K. K. V. O.
    Ribeiro Junior, C. L.
    da Costa, I. R.
    GENETICS AND MOLECULAR RESEARCH, 2019, 18 (02)
12345